(永久免费)加速器下载官网

(永久免费)加速器下载官网

Male Apellis employee holding a horse saddle

Luis
Supply Chain at Apellis

(永久免费)加速器下载官网

Learn More
Folded page of a newspaper

(永久免费)加速器下载官网

(永久免费)加速器下载官网

Apellis Pharmaceuticals Reports Second Quarter 2023 Financial Results

(永久免费)加速器下载官网

Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA)

w加速器官网

Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Newsroom
w加速器安卓

@ApellisPharma

A man with a baby in a baby carrier

(永久免费)加速器下载官网

FOR PATIENTS
Erlenmeyer flask, which represents the pre-clinical and clinical studies sponsored by Apellis Pharmaceuticals

(永久免费)加速器下载官网

for paroxysmal nocturnal hemoglobinuria, geographic atrophy,
C3 glomerulopathy, and cold agglutinin disease.

PIPELINE
3 arrows of different lengths, which represents the development status of pre-clinical and clinical studies for C3 complement targeted therapies

(永久免费)加速器下载官网

are targeted C3 therapies. These include potential medicines for a broad range of serious diseases driven by uncontrolled or excessive activation of the complement system.

CLINICAL TRIALS

(永久免费)加速器下载官网

so that Alexander, who is living with C3 glomerulopathy, can take his pug for a hike

We challenge conventional thinking and always question if there's a better way.

Join Us
w加速器app

Patricia
Quality Assurance at Apellis

快橙app下载  旋风vnp最新版  蝙蝠加速器官网  灯蓝加速器下载  快连pro加速器  旋风vp n  老王加速器app  letsvpvn官网